D-Erythro-2,3-dihydroxy-1-(1-phenyl-1H-pyrazolo(3,4-b)quinoxalin-3-y l)-propyl-4-O-.alpha.-D-glucopyranosyl-alpha-D-glucopyranoside poly(H-sulfate)salts
US4304903A · kind A · utility
6Cited by
4References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 1980 |
| Grant date | Dec 8, 1981 |
| Priority date | — |
| Expiry date | Mar 3, 2000 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/26
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
D-Erythro-2,3-dihydroxy-1-[substituted and unsubstituted)-1-phenyl-1H-pyrazolo[3,4-b]quinoxalin-3-yl]propyl-4-O-.alph a.-D-glucopyranosyl-.alpha.-D-glucopyranoside poly(H-sulfate)salts useful as complement inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.